top TOP
December 13, 2019

Ronit Satchi-Fainaro, PhD

Tel Aviv University

ICRF Research Professorship Grant Recipient

Prof. Satchi-Fainaro has been a full Professor at Tel Aviv University since 2015, Head of the Cancer Research & Nanomedicine Laboratory since 2006, Chair of the Department of Physiology & Pharmacology at the Sackler Faculty of Medicine since 2014, Chair of The Kurt and Herman Lion Cathedra in Nanosciences and Nanotechnologies since 2017, and a member of the Preclinical Dean’s Committee since 2015.

She received her BPharm from The Hebrew University of Jerusalem in 1995 and her PhD in Polymer Chemistry and Cancer Nanomedicine from the University of London in 1999 with Prof. Ruth Duncan. She then spent two years as a Postdoctoral Research Fellow on Biochemistry and Protein Delivery at Tel Aviv University and two years as a Postdoctoral Research Fellow at Harvard University and Children’s Hospital Boston working with Prof. Judah Folkman on Vascular and Cancer Biology.

In 2003, Prof. Satchi-Fainaro was appointed Instructor in Surgery at Boston Children’s Hospital and Harvard Medical School, where she has been a Visiting Associate Professor since 2005. She joined Tel Aviv University in 2006.

Prof. Satchi-Fainaro also serves as a consultant to several biotech and pharmaceutical companies, as a member of the Board of Directors of Teva Pharmaceuticals Industries Ltd., member of the scientific advisory board of the Blavatnik Center for Drug Discovery, The Israel Cancer Association, Vall d’Hebron University Hospital Foundation Research Institute, and of several editorial boards of scientific journals.

Her multidisciplinary research laboratory focuses on basic research elucidating the mechanisms underlying the switch from cancer dormancy leading to the discovery of new molecular targets interrupting tumor-host interactions. Her approach is followed by the design of highly-selective targeting molecules integrating biology, chemistry, medicine and nanotechnology to selectively guide drugs into pathological sites. Throughout, Prof. Satchi-Fainaro has maintained an interest in understanding the biological rationale for the design of nanomedicines suitable for transfer into clinical testing.

She has published more than 100 manuscripts, 12 book chapters, edited two books, is named inventor on 47 patents, and was awarded numerous prestigious grants and prizes. Her scientific achievements were acknowledged numerous times by inclusion in honorary lists in ForbesGlobesThe Marker 40/40Calcalist, etc. She was recently elected the next 2019 Chair of the Gordon Research Conference on Cancer Nanomedicine. She was awarded an ICRF Research Professorship Grant in 2018.

Help End the Suffering Caused By Cancer

The answer to cancer is research. Support groundbreaking cancer research in Israel today: